Chemotherapy-Free Treatment of Follicular Lymphoma: We Have the Ingredients, Now for Some Recipes

被引：0
|
作者：
Cheah, Chan Yoon [1 ,2 ,3 ]
Fowler, Nathan H. [4 ]
机构：
[1] PathWest Lab Med WA, Dept Hematol, Nedlands, WA, Australia
[2] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
ONCOLOGY-NEW YORK | 2015年 / 29卷 / 10期
关键词：
1ST-LINE TREATMENT; OPEN-LABEL; RITUXIMAB; INDOLENT; IBRUTINIB; LENALIDOMIDE; IDELALISIB; INHIBITION; RISK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：769 / 772
页数：2
相关论文
共 50 条
  • [31] Successful treatment of gastrointestinal follicular lymphoma with rituxan and combination chemotherapy
    Al-Salman, J
    Salib, H
    Boonswang, P
    MEDICAL ONCOLOGY, 2001, 18 (04) : 277 - 283
  • [32] Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)
    Moccia, Alden Alberto
    Schaer, Saemi
    Hayoz, Stefanie
    Pirosa, Maria Cristina
    Taverna, Christian
    Novak, Urban
    Kimby, Eva
    Ghielmini, Michele
    Zucca, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (06) : 1031 - 1034
  • [33] Time-limited, chemotherapy-free treatment comes of age in chronic leukaemia Comment
    Molica, Stefano
    Allsup, David John
    LANCET ONCOLOGY, 2022, 23 (06) : 699 - 701
  • [34] Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
  • [35] Chemotherapy-free Treatment of Patients with BRAFV600E mutated metastatic Colorectal Cancer
    Fabre, Pierre
    VISCERAL MEDICINE, 2020, 36 (03) : 251 - 251
  • [36] The cost-effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma
    Prettyjohns, Matthew
    Hoskin, Peter
    McNamara, Christopher
    Linch, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 52 - 59
  • [37] Chemotherapy-free, triple combination of obinutuzumab, venetoclax and idasanutlin: antitumor activity in xenograft models of non-Hodgkin lymphoma
    Herting, Frank
    Friess, Thomas
    Umana, Pablo
    Middleton, Steven
    Klein, Christian
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1482 - 1485
  • [38] Tailoring treatment for MALT lymphoma patients: where do we stand now?
    Johnson, Peter W.
    Thieblemont, Catherine
    Zucca, Emanuele
    ONCOTARGET, 2017, 8 (70) : 114422 - 114423
  • [39] Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions
    Ng, Samuel Y.
    Abramson, Jeremy S.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (04) : 371 - 376
  • [40] Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
    Lockmer, Sandra
    Ostenstad, Bjorn
    Hagberg, Hans
    Holte, Harald
    Johansson, Ann-Sofie
    Wahlin, Bjorn Engelbrekt
    Wader, Karin Fahl
    Steen, Chloe Beate
    Meyer, Peter
    Maisenholder, Martin
    Smedby, Karin Ekstrom
    Brown, Peter
    Kimby, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (33) : 3315 - +
12345